A prospective randomised controlled phase III trial of gemcitabine and docetaxel compared with doxorubicin as first line treatment in previously untreated advanced unresectable or metastatic soft tiss...

Update Il y a 5 ans
Reference: EUCTR2009-014907-29

A prospective randomised controlled phase III trial of gemcitabine and docetaxel compared with doxorubicin as first line treatment in previously untreated advanced unresectable or metastatic soft tissue sarcomas

Woman and Man

  • | Country :
  • -
  • | organs :
  • -
  • | Specialty :
  • -

Extract

The principal research objective is to compare the efficacy and effectiveness of gemcitabine and docetaxel with that of doxorubicin.


Inclusion criteria

  • Locally Advanced Unresectable or Metastatic Soft Tissue Sarcoma